Comparison Of Progesterone-Induced Blocking Factor Serum Levels In Preterm Labor And Preterm Pregnancy
DOI:
https://doi.org/10.19166/med.v7i2.1793Keywords:
PIBF, preterm labor, progesteroneAbstract
Preterm labor is a multifactorial phenomenon involving inflammatory processes that will affect the balance of Th1 to Th2 by increasing dominance of pro-inflammatory Th1 cytokines and also lead to functional progesterone withdrawal.
Progesterone maintains pregnancy mainly by promoting myometrial quiescence and labor is initiated by progesterone withdrawal. Progesterone also has antiinflammatory properties and as an immunomodulator. While it has been postulated that the effect of progesterone on preterm birth is related to its anti-inflammatory properties, the spesific mechanism of action remains unclear.
The biological effects of progesterone are mediated by a 34-kDa protein named the progesterone-induced blocking factor (PIBF). PIBF is synthesized by lymphocytes of healthy pregnant women in the presence of progesterone. PIBF inhibits arachidonic acid production, reduced NK cell activity, and modifies the cytokine balance.
The objective of this study was to compare serum concentrations of PIBF of women with preterm labor with those women with normal pregnancy. A comparative analytical study with cross-sectional design was conducted. This study consisted of 16 women in each group. All the subjects met the inclusion criteria and were admitted to the Dr . Hasan Sadikin hospital and it’s district hospital. This study conducted from July until November 2013. Serum PIBF concentrations were measured by enzyme-linked immunosorbent assay ( ELISA) .
Mean PIBF concentrations in serum of patients with preterm labor were significantly lower (391.4051 ± 1021.162 ng/mL ) than in those of normal pregnancy (174.2165 ± 1297.675 ng/mL) with p = 0.029 . It was concluded that the levels of serum PIBF preterm labor is lower than in normal pregnancy.
References
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75-84.
Slattery MM, Morrison JJ. Preterm delivery. Lancet. 2002;360:1489-97.
Vogel I, Thorsen P, Curry A, Sandager P, Uldbjerg N. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand. 2005;84(6):516-25.
Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG. 2006;113 Suppl 3:17-42.
Rey G, Pereyra S, Velazquez T, Grasso D, Alonso J, Bertoni B, et al. The effect of inflammation on preterm birth. Dalam: Morrison JC. Preterm Birth - Mother and Child. Croatia: InTech; 2011. h. 183-200.
Keelan JA. Pharmacological inhibition of inflammatory pathways for the prevention of preterm birth. J Reprod Immunol. 2011;88(2):176-84.
Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med. 2006;11(5):317-26.
Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol. 2008;79(1):50-7.
Raghupathy R, Al-Mutawa E, Al-Azemi M, Makhseed M, Azizieh F, Szekeres-Bartho J. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J Reprod Immunol. 2009;80(1):91-9.
Vrachnis N, Malamas FM, Sifakis S, Tsikouras P, Iliodromiti Z. Immune aspects and myometrial actions of progesterone and CRH in labor. Clin Dev Immunol. 2012;2012:1-10.
Challis JR, Sloboda DM, Alfaidy N, Lye SJ, Gibb W, Patel FA, et al. Prostaglandins and mechanisms of preterm birth. Reproduction. 2002;124(1):1-17.
Brown AG, Leite RS, Strauss JF, 3rd. Mechanisms underlying "functional" progesterone withdrawal at parturition. Ann N Y Acad Sci. 2004;1034:36-49.
Strauss JF, Barbieri RL. Yen and Jaffe's reproductive endocrinology : physiology, pathophysiology, and clinical management. Edisi ke-6. Philadelphia, PA: Saunders/Elsevier; 2009.
Polgar B, Nagy E, Miko E, Varga P, Szekeres-Bartho J. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol Reprod. 2004;71(5):1699-705.
Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palkovics T, Szereday L. Progesterone as an immunomodulatory molecule. International Immunopharmacology. 2001;1(6):1037-48.
Hudic I, Fatusic Z. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion. J Perinat Med. 2009;37(4):338-42.
Hudic I, Fatusic Z, Szekeres-Bartho J, Balic D, Polgar B, Ljuca D, et al. Progesterone-induced blocking factor and cytokine profile in women with threatened pre-term delivery. Am J Reprod Immunol. 2009;61(5):330-7.
Sfakianaki AK, Norwitz ER. Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med. 2006;19(12):763-72.
Oleszczuk J, Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J. Alterations in the immune system of patients with imminent preterm labour. Gynecol Obstet Invest. 2000;49(2):110-3.
Druckmann R, Druckmann MA. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol. 2005;97(5):389-96.
Formosa M. The paradox of pregnancy: an update on the immunology of early pregnancy. Malta Medical Journal. 2008;20(2):10-4.
Sykes L, MacIntyre DA, Yap XJ, Teoh TG, Bennett PR. The Th1:th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm. 2012;2012:1-12.
da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003;188(2):419-24.
Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348(24):2379-85.
Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, et al. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery. Am J Obstet Gynecol. 2005;193(3):1127-31.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
